Telemedical Interventional Management in Heart Failure II

Inclusion Criteria: * chronic heart failure New York Heart Association (NYHA) class II or III * echocardiographically determined left ventricular ejection fraction (LVEF) ≤45% or \>45% + minimum 1 diuretic in permanent medicinal therapy * hospitalization due to decompensated HF within the last 12months before randomization * informed consent * Depression score PHQ-9: \<10 Exclusion Criteria: * hospitalization within the last 7 days before randomization * implanted cardiac assist system * acute coronary syndrome within the last 7 days before randomization * high urgent listed for heart transplantation (HTx) * planned revascularization, Transcatheter Aortic Valve Implantation (TAVI), MitraClip and/or Cardiac Resynchronization Therapy (CRT)-implantation within the last 3 months before randomization * revascularization and/or CRT-implantation within 28 days before randomization * known alcohol or drug abuse * terminal renal insufficiency with hemodialysis * impairment or unwillingness to use the telemonitoring equipment (e.g. dementia, impaired self-determination, lacking ability to communicate) * existence of any disease reducing life expectancy to less than 1 year * age \<18 years * pregnancy * participation in other treatment studies or remote patient management programmes (register studies possible)